Overall Technical outlook

Price Summary

NATCO Pharma Limited's stock started the year at 1015.0, climbed to a high of 1047.7, fell to 1007.0, and closed 0.63% higher at 1021.35, with 1674746 shares traded on 2025-07-16.
For the 52-week period, the stock's highest price is 1592.85, and the lowest price is 746.5.
Future price predictions suggest a range between 697.0 and 1480.0, with an average expected price of 967.4545, as per 11 analysts.

Technicals

Support and Resistance: The price is currently at 1021.35, supported by 973.6 and resisted by 1146.35. This indicates a range where 973.6 may provide a base for the price, while 1146.35 serves as a cap on further upward movement for NATCOPHARM.
NATCOPHARM supportResistance 9b5105
Support/Resistance for NATCOPHARM


Aroon: Aroon's bullish trend continues, with Aroon Up at the 100 level, indicating sustained market strength for NATCOPHARM. This trend warrants further exploration alongside other indicators to fully understand its implications and potential future direction.
NATCOPHARM aroon 9b5105
Aroon chart for NATCO Pharma Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
NATCOPHARM bbands 9b5105
Bolinger Bands chart for NATCO Pharma Limited


Parabolic SAR: The PSAR remains bullish, setting a strong support level that could underpin further upward movement. This persistent bullish outlook suggests that the market may continue its positive trajectory, with the established support acting as a safety net.
NATCOPHARM psar 9b5105
Parabolic Stop and Reverse chart for NATCO Pharma Limited


Stochastic: The stochastic indicator shows a bullish signal, with the K-line exceeding both the D-line and the 80 mark. This setup suggests strong upward momentum, implying that the market may continue to rise. Investors could consider this a favorable sign for continued market growth for NATCO Pharma Limited.
NATCOPHARM stoch 9b5105
Stochastic chart for NATCO Pharma Limited


Tripple Moving Agerage: The current reading of the Tripple MOVING AVG is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
NATCOPHARM trippleSMA 9b5105
Tripple SMA chart for NATCO Pharma Limited


Before diving into the technical aspects of a company, such as stock price charts or volume trends, it's important to understand its fundamentals. These fundamentals include financial stability, growth potential, and strategic positioning. Additionally, knowing the broader industry landscape, including competitive pressures and regulatory factors, offers deeper insights. When this fundamental analysis is combined with technical indicators, it leads to more informed, accurate evaluations of the company's overall performance.